metabolite_name,chemical_formula,smiles,inchikey,name,smpdb_id,kegg_map_id
3-Hydroxybutyric acid,C4H8O3,C[C@@H](O)CC(O)=O,WHBMMWSBFZVSSR-GSVOUGTGSA-N,Fatty Acid Biosynthesis,SMP00456,
3-Hydroxybutyric acid,C4H8O3,C[C@@H](O)CC(O)=O,WHBMMWSBFZVSSR-GSVOUGTGSA-N,Ketone Body Metabolism,SMP00071,map00072
3-Hydroxybutyric acid,C4H8O3,C[C@@H](O)CC(O)=O,WHBMMWSBFZVSSR-GSVOUGTGSA-N,Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMP00569,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
p-Hydroxyphenylacetic acid,C8H8O3,OC(=O)CC1=CC=C(O)C=C1,XQXPVVBIMDBYFF-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Butyric acid,C4H8O2,CCCC(O)=O,FERIUCNNQQJTOY-UHFFFAOYSA-N,Butyrate Metabolism,SMP00073,map00650
Butyric acid,C4H8O2,CCCC(O)=O,FERIUCNNQQJTOY-UHFFFAOYSA-N,Fatty Acid Biosynthesis,SMP00456,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Amino Sugar Metabolism,SMP00045,map00520
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Aspartate Metabolism,SMP00067,map00250
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Canavan Disease,SMP00175,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Ethanol Degradation,SMP00449,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Fatty Acid Biosynthesis,SMP00456,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",SMP00534,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Heroin Action Pathway,SMP00407,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Heroin Metabolism Pathway,SMP00623,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Hypoacetylaspartia,SMP00192,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Leigh Syndrome,SMP00196,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Pyruvate kinase deficiency,SMP00559,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Pyruvate metabolism,,map00620
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Salla Disease/Infantile Sialic Acid Storage Disease,SMP00240,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Sialuria or French Type Sialuria,SMP00216,
Acetic acid,C2H4O2,CC(O)=O,QTBSBXVTEAMEQO-UHFFFAOYSA-N,Tay-Sachs Disease,SMP00390,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Alkaptonuria,SMP00169,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Aromatic L-Aminoacid Decarboxylase Deficiency,SMP00170,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Carnitine Synthesis,SMP00465,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Disulfiram Action Pathway,SMP00429,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Hawkinsinuria,SMP00190,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Oxidation of Branched Chain Fatty Acids,SMP00030,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Phytanic Acid Peroxisomal Oxidation,SMP00450,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Refsum Disease,SMP00451,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,The Oncogenic Action of Fumarate,SMP02295,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,The Oncogenic Action of Succinate,SMP02292,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Tyrosine hydroxylase deficiency,SMP00497,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Tyrosine metabolism,,map00350
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Tyrosine metabolism,,map00350
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,Tyrosinemia Type I,SMP00218,
Ascorbic acid,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Melibiose,C12H22O11,OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O,DLRVVLDZNNYCBX-CQHUIXDMSA-N,Galactose Metabolism,SMP00043,map00052
Melibiose,C12H22O11,OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O,DLRVVLDZNNYCBX-CQHUIXDMSA-N,Galactosemia,SMP00182,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Alkaptonuria,SMP00169,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Aromatic L-Aminoacid Decarboxylase Deficiency,SMP00170,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Disulfiram Action Pathway,SMP00429,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Epinephrine Action Pathway,SMP00661,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Hawkinsinuria,SMP00190,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Tyrosine hydroxylase deficiency,SMP00497,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Tyrosine metabolism,,map00350
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Tyrosine metabolism,,map00350
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Tyrosinemia Type I,SMP00218,
Epinephrine,C9H13NO3,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3-Methylthiofentanyl Action Pathway,SMP00679,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Alfentanil Action Pathway,SMP00413,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Alvimopan Action Pathway,SMP00685,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Anileridine Action Pathway,SMP00674,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Aromatic L-Aminoacid Decarboxylase Deficiency,SMP00170,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Benzocaine Action Pathway,SMP00392,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Bupivacaine Action Pathway,SMP00393,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Buprenorphine Action Pathway,SMP00684,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Carfentanil Action Pathway,SMP00414,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Chloroprocaine Action Pathway,SMP00394,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Citalopram Action Pathway,SMP00424,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Cocaine Action Pathway,SMP00395,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Codeine Action Pathway,SMP00405,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Desipramine Action Pathway,SMP00423,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dezocine Action Pathway,SMP00676,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dibucaine Action Pathway,SMP00396,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dihydromorphine Action Pathway,SMP00689,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dimethylthiambutene Action Pathway,SMP00680,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Diphenoxylate Action Pathway,SMP00675,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dopamine Activation of Neurological Reward System,SMP00308,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Escitalopram Action Pathway,SMP00425,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Ethylmorphine Action Pathway,SMP00681,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Fentanyl Action Pathway,SMP00415,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Fluoxetine Action Pathway,SMP00426,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Heroin Action Pathway,SMP00407,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Hydrocodone Action Pathway,SMP00411,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Hydromorphone Action Pathway,SMP00410,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Imipramine Action Pathway,SMP00422,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Ketobemidone  Action Pathway,SMP00690,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Levallorphan Action Pathway,SMP00683,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Levobupivacaine Action Pathway,SMP00397,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Levomethadyl Acetate Action Action Pathway,SMP00677,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Levorphanol Action Pathway,SMP00673,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Lidocaine (Local Anaesthetic) Action Pathway,SMP00398,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Mepivacaine Action Pathway,SMP00399,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Methadone Action Pathway,SMP00408,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Methadyl Acetate Action Pathway,SMP00678,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Morphine Action Pathway,SMP00406,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Nalbuphine Action Pathway,SMP00691,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Naloxone Action Pathway,SMP00688,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Naltrexone Action Pathway,SMP00687,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Nicotine Action Pathway,SMP00431,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Oxybuprocaine Action Pathway,SMP00400,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Oxycodone Action Pathway,SMP00409,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Oxymorphone Action Pathway,SMP00412,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Pentazocine Action Pathway,SMP00686,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Prilocaine Action Pathway,SMP00401,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Procaine Action Pathway,SMP00402,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Proparacaine Action Pathway,SMP00403,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Propoxyphene Action Pathway,SMP00672,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Remifentanil Action Pathway,SMP00416,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Ropivacaine Action Pathway,SMP00404,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Sufentanil Action Pathway,SMP00417,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Tramadol Action Action Pathway,SMP00671,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Tyrosine hydroxylase deficiency,SMP00497,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
Dopamine,C8H11NO2,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Dimethylamine,C2H7N,CNC,ROSDSFDQCJNGOL-UHFFFAOYSA-N,Citalopram Action Pathway,SMP00424,
Dimethylamine,C2H7N,CNC,ROSDSFDQCJNGOL-UHFFFAOYSA-N,Citalopram Metabolism Pathway,SMP00627,
Ethanol,C2H6O,CCO,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Ethanol,C2H6O,CCO,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,Ethanol Degradation,SMP00449,
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,2-Hydroxyglutric Aciduria (D And L Form),SMP00136,
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMP00243,
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,Glutamate Metabolism,SMP00072,map00250
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,Homocarnosinosis,SMP00385,
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,Hyperinsulinism-Hyperammonemia Syndrome,SMP00339,
gamma-Aminobutyric acid,C4H9NO2,NCCCC(O)=O,BTCSSZJGUNDROE-UHFFFAOYSA-N,Succinic semialdehyde dehydrogenase deficiency,SMP00567,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
Homovanillic acid,C9H10O4,COC1=C(O)C=CC(CC(O)=O)=C1,QRMZSPFSDQBLIX-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Folic acid,C19H19N7O6,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,"Folate malabsorption, hereditary",SMP00724,
Folic acid,C19H19N7O6,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,Methotrexate Action Pathway,SMP00432,
Folic acid,C19H19N7O6,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMP00543,
Folic acid,C19H19N7O6,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,One carbon pool by folate,,map00670
Folic acid,C19H19N7O6,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,Pterine Biosynthesis,SMP00005,map00790
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,27-Hydroxylase Deficiency,SMP00720,
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Cerebrotendinous Xanthomatosis (CTX),SMP00315,
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Congenital Bile Acid Synthesis Defect Type II,SMP00314,
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Congenital Bile Acid Synthesis Defect Type III,SMP00318,
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Familial Hypercholanemia (FHCA),SMP00317,
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Primary bile acid biosynthesis,,map00120
Glycocholic acid,C26H43NO6,C[C@H](CCC(O)=NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,RFDAIACWWDREDC-FRVQLJSFSA-N,Zellweger Syndrome,SMP00316,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMP00356,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Alendronate Action Pathway,SMP00095,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Androgen and Estrogen Metabolism,SMP00068,map00150
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Androstenedione Metabolism,SMP30406,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Aromatase deficiency,SMP00565,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Atorvastatin Action Pathway,SMP00131,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Cerivastatin Action Pathway,SMP00111,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,CHILD Syndrome,SMP00387,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Cholesteryl ester storage disease,SMP00508,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,"Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)",SMP00388,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Desmosterolosis,SMP00386,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Dopa-responsive dystonia,SMP00486,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Fluvastatin Action Pathway,SMP00119,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,"Folate malabsorption, hereditary",SMP00724,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Hyper-IgD syndrome,SMP00509,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Hypercholesterolemia,SMP00209,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,SMP00487,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),SMP00488,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Hyperphenylalaninemia due to dhpr-deficiency,SMP00489,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Ibandronate Action Pathway,SMP00079,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Lovastatin Action Pathway,SMP00099,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Lysosomal Acid Lipase Deficiency (Wolman Disease),SMP00319,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Methotrexate Action Pathway,SMP00432,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMP00543,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Mevalonic aciduria,SMP00510,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,One carbon pool by folate,,map00670
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Pamidronate Action Pathway,SMP00117,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Pravastatin Action Pathway,SMP00089,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Pterine Biosynthesis,SMP00005,map00790
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Risedronate Action Pathway,SMP00112,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Rosuvastatin Action Pathway,SMP00092,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Segawa syndrome,SMP00490,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Sepiapterin reductase deficiency,SMP00491,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Simvastatin Action Pathway,SMP00082,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Smith-Lemli-Opitz Syndrome (SLOS),SMP00389,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Steroid Biosynthesis,SMP00023,map00100
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Tryptophan metabolism,,map00380
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Wolman disease,SMP00511,
Formic acid,CH2O2,OC=O,BDAGIHXWWSANSR-UHFFFAOYSA-N,Zoledronate Action Pathway,SMP00107,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,"Fructose-1,6-diphosphatase deficiency",SMP00562,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Glutaminolysis and Cancer,SMP02298,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMP00374,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,"Glycogenosis, Type IA. Von gierke disease",SMP00581,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,"Glycogenosis, Type IB",SMP00573,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,"Glycogenosis, Type IC",SMP00574,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Glycolysis / Gluconeogenesis,,map00010
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Leigh Syndrome,SMP00196,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMP00560,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Pyruvate kinase deficiency,SMP00559,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Pyruvate metabolism,,map00620
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Triosephosphate isomerase,SMP00563,
L-Lactic acid,C3H6O3,C[C@H](O)C(O)=O,JVTAAEKCZFNVCJ-REOHCLBHSA-N,Warburg Effect,SMP00654,
Indoleacetic acid,C10H9NO2,OC(=O)CC1=CNC2=C1C=CC=C2,SEOVTRFCIGRIMH-UHFFFAOYSA-N,Tryptophan metabolism,,map00380
Phenylpyruvic acid,C9H8O3,OC(=O)C(=O)CC1=CC=CC=C1,BTNMPGBKDVTSJY-UHFFFAOYSA-N,Phenylalanine and Tyrosine Metabolism,SMP00008,map00360
Phenylpyruvic acid,C9H8O3,OC(=O)C(=O)CC1=CC=CC=C1,BTNMPGBKDVTSJY-UHFFFAOYSA-N,Phenylketonuria,SMP00206,
Phenylpyruvic acid,C9H8O3,OC(=O)C(=O)CC1=CC=CC=C1,BTNMPGBKDVTSJY-UHFFFAOYSA-N,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMP00369,
Phenylpyruvic acid,C9H8O3,OC(=O)C(=O)CC1=CC=CC=C1,BTNMPGBKDVTSJY-UHFFFAOYSA-N,Tyrosinemia Type 3 (TYRO3),SMP00370,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,2-aminoadipic 2-oxoadipic aciduria,SMP00719,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,2-Hydroxyglutric Aciduria (D And L Form),SMP00136,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,2-ketoglutarate dehydrogenase complex deficiency,SMP00549,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMP00137,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMP00138,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-hydroxyisobutyric acid dehydrogenase deficiency,SMP00521,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-hydroxyisobutyric aciduria,SMP00522,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMP00237,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type I,SMP00139,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type III,SMP00140,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type IV,SMP00141,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,3-Phosphoglycerate dehydrogenase deficiency,SMP00721,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMP00243,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Alanine, aspartate and glutamate metabolism",,map00250
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Arginine and proline metabolism,,map00330
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMP00362,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Argininemia,SMP00357,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Argininosuccinic Aciduria,SMP00003,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Aspartate Metabolism,SMP00067,map00250
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,beta-Alanine metabolism,,map00410
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Beta-Ketothiolase Deficiency,SMP00173,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Beta-mercaptolactate-cysteine disulfiduria,SMP00499,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Canavan Disease,SMP00175,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Carbamoyl Phosphate Synthetase Deficiency,SMP00002,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Carnitine Synthesis,SMP00465,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Carnosinuria, carnosinemia",SMP00493,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Citric Acid Cycle,SMP00057,map00020
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Citrullinemia Type I,SMP00001,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Congenital lactic acidosis,SMP00546,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",SMP00504,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Cysteine Metabolism,SMP00013,map00270
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Cystinosis, ocular nonnephropathic",SMP00722,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMP00179,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Dimethylglycine Dehydrogenase Deficiency,SMP00242,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Dimethylglycine Dehydrogenase Deficiency,SMP00484,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Fructose-1,6-diphosphatase deficiency",SMP00562,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Fumarase deficiency,SMP00547,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,GABA-Transaminase Deficiency,SMP00351,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glucose-Alanine Cycle,SMP00127,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glutamate Metabolism,SMP00072,map00250
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glutaminolysis and Cancer,SMP02298,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glutaric Aciduria Type I,SMP00186,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Glycine, serine and threonine metabolism",,map00260
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMP00374,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Glycogenosis, Type IA. Von gierke disease",SMP00581,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Glycogenosis, Type IB",SMP00573,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Glycogenosis, Type IC",SMP00574,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Glycolysis / Gluconeogenesis,,map00010
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMP00188,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Homocarnosinosis,SMP00385,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Hyperglycinemia, non-ketotic",SMP00485,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperinsulinism-Hyperammonemia Syndrome,SMP00339,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Hyperlysinemia I, Familial",SMP00527,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperlysinemia II or Saccharopinuria,SMP00528,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperornithinemia with gyrate atrophy (HOGA),SMP00505,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMP00506,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperprolinemia Type I,SMP00361,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hyperprolinemia Type II,SMP00360,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Hypoacetylaspartia,SMP00192,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Isobutyryl-coa dehydrogenase deficiency,SMP00523,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Isovaleric acidemia,SMP00524,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Isovaleric Aciduria,SMP00238,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,L-arginine:glycine amidinotransferase deficiency,SMP00507,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Lactic Acidemia,SMP00313,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Lysine degradation,,map00310
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Malate-Aspartate Shuttle,SMP00129,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Malonic Aciduria,SMP00198,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Malonyl-coa decarboxylase deficiency,SMP00502,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Maple Syrup Urine Disease,SMP00199,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMP00384,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Methylmalonic Aciduria,SMP00200,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMP00201,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Mitochondrial complex II deficiency,SMP00548,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Nitrogen metabolism,,map00910
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Non Ketotic Hyperglycinemia,SMP00223,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Ornithine Aminotransferase Deficiency (OAT Deficiency),SMP00363,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMP00205,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Oxidation of Branched Chain Fatty Acids,SMP00030,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Phenylalanine and Tyrosine Metabolism,SMP00008,map00360
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Phenylketonuria,SMP00206,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMP00560,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Phytanic Acid Peroxisomal Oxidation,SMP00450,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Primary Hyperoxaluria Type I,SMP00352,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Prolidase Deficiency (PD),SMP00207,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Prolinemia Type II,SMP00208,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Propanoate metabolism,,map00640
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Propionic Acidemia,SMP00236,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Pyridoxine dependency with seizures,SMP00571,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Pyruvate Carboxylase Deficiency,SMP00350,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E2),SMP00551,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E3),SMP00550,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Refsum Disease,SMP00451,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Saccharopinuria/Hyperlysinemia II,SMP00239,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Sarcosinemia,SMP00244,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Succinic semialdehyde dehydrogenase deficiency,SMP00567,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,The oncogenic action of 2-hydroxyglutarate,SMP02291,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMP02359,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,The Oncogenic Action of Fumarate,SMP02295,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMP02358,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,The Oncogenic Action of Succinate,SMP02292,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Triosephosphate isomerase,SMP00563,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Tryptophan metabolism,,map00380
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMP00369,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Tyrosinemia Type 3 (TYRO3),SMP00370,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Urea Cycle,SMP00059,map00330
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Ureidopropionase Deficiency,SMP00492,
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,"Valine, leucine and isoleucine degradation",,map00280
Oxoglutaric acid,C5H6O5,OC(=O)CCC(=O)C(O)=O,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Warburg Effect,SMP00654,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,3-Methylthiofentanyl Action Pathway,SMP00679,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Alfentanil Action Pathway,SMP00413,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Alkaptonuria,SMP00169,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Alvimopan Action Pathway,SMP00685,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Anileridine Action Pathway,SMP00674,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Aromatic L-Aminoacid Decarboxylase Deficiency,SMP00170,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Benzocaine Action Pathway,SMP00392,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Bupivacaine Action Pathway,SMP00393,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Buprenorphine Action Pathway,SMP00684,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Carfentanil Action Pathway,SMP00414,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Chloroprocaine Action Pathway,SMP00394,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Citalopram Action Pathway,SMP00424,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Cocaine Action Pathway,SMP00395,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Codeine Action Pathway,SMP00405,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Desipramine Action Pathway,SMP00423,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dezocine Action Pathway,SMP00676,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dibucaine Action Pathway,SMP00396,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dihydromorphine Action Pathway,SMP00689,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dimethylthiambutene Action Pathway,SMP00680,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Diphenoxylate Action Pathway,SMP00675,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Disulfiram Action Pathway,SMP00429,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Escitalopram Action Pathway,SMP00425,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Ethylmorphine Action Pathway,SMP00681,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Fentanyl Action Pathway,SMP00415,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Fluoxetine Action Pathway,SMP00426,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Hawkinsinuria,SMP00190,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Heroin Action Pathway,SMP00407,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Hydrocodone Action Pathway,SMP00411,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Hydromorphone Action Pathway,SMP00410,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Imipramine Action Pathway,SMP00422,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Ketobemidone  Action Pathway,SMP00690,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Levallorphan Action Pathway,SMP00683,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Levobupivacaine Action Pathway,SMP00397,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Levomethadyl Acetate Action Action Pathway,SMP00677,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Levorphanol Action Pathway,SMP00673,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Lidocaine (Local Anaesthetic) Action Pathway,SMP00398,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Mepivacaine Action Pathway,SMP00399,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Methadone Action Pathway,SMP00408,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Methadyl Acetate Action Pathway,SMP00678,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Morphine Action Pathway,SMP00406,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Nalbuphine Action Pathway,SMP00691,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Naloxone Action Pathway,SMP00688,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Naltrexone Action Pathway,SMP00687,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Nicotine Action Pathway,SMP00431,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Oxybuprocaine Action Pathway,SMP00400,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Oxycodone Action Pathway,SMP00409,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Oxymorphone Action Pathway,SMP00412,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Pentazocine Action Pathway,SMP00686,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Prilocaine Action Pathway,SMP00401,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Procaine Action Pathway,SMP00402,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Proparacaine Action Pathway,SMP00403,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Propoxyphene Action Pathway,SMP00672,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Remifentanil Action Pathway,SMP00416,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Ropivacaine Action Pathway,SMP00404,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Sufentanil Action Pathway,SMP00417,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Tramadol Action Action Pathway,SMP00671,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Tyrosine hydroxylase deficiency,SMP00497,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Tyrosine metabolism,,map00350
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Tyrosine metabolism,,map00350
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Tyrosinemia Type I,SMP00218,
Norepinephrine,C8H11NO3,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Phenol,C6H6O,OC1=CC=CC=C1,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,Sulfite oxidase deficiency,SMP00532,
Phenol,C6H6O,OC1=CC=CC=C1,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,Sulfur metabolism,,map00920
Propionic acid,C3H6O2,CCC(O)=O,XBDQKXXYIPTUBI-UHFFFAOYSA-N,Malonic Aciduria,SMP00198,
Propionic acid,C3H6O2,CCC(O)=O,XBDQKXXYIPTUBI-UHFFFAOYSA-N,Malonyl-coa decarboxylase deficiency,SMP00502,
Propionic acid,C3H6O2,CCC(O)=O,XBDQKXXYIPTUBI-UHFFFAOYSA-N,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMP00201,
Propionic acid,C3H6O2,CCC(O)=O,XBDQKXXYIPTUBI-UHFFFAOYSA-N,Propanoate metabolism,,map00640
Propionic acid,C3H6O2,CCC(O)=O,XBDQKXXYIPTUBI-UHFFFAOYSA-N,Vitamin K Metabolism,SMP00464,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,2-Hydroxyglutric Aciduria (D And L Form),SMP00136,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,2-ketoglutarate dehydrogenase complex deficiency,SMP00549,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,3-Phosphoglycerate dehydrogenase deficiency,SMP00721,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMP00243,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Alanine, aspartate and glutamate metabolism",,map00250
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Amino Sugar Metabolism,SMP00045,map00520
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Argininemia,SMP00357,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Argininosuccinic Aciduria,SMP00003,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Beta-mercaptolactate-cysteine disulfiduria,SMP00499,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Carbamoyl Phosphate Synthetase Deficiency,SMP00002,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Citric Acid Cycle,SMP00057,map00020
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Citrullinemia Type I,SMP00001,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Congenital lactic acidosis,SMP00546,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Cysteine Metabolism,SMP00013,map00270
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Cystinosis, ocular nonnephropathic",SMP00722,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMP00179,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Dimethylglycine Dehydrogenase Deficiency,SMP00242,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Dimethylglycine Dehydrogenase Deficiency,SMP00484,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Fanconi-bickel syndrome,SMP00572,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Fructose-1,6-diphosphatase deficiency",SMP00562,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Fumarase deficiency,SMP00547,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",SMP00534,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glucose-Alanine Cycle,SMP00127,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glutamate Metabolism,SMP00072,map00250
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glutaminolysis and Cancer,SMP02298,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Glycine, serine and threonine metabolism",,map00260
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMP00374,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Glycogenosis, Type IA. Von gierke disease",SMP00581,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Glycogenosis, Type IB",SMP00573,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Glycogenosis, Type IC",SMP00574,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Glycogenosis, Type VII. Tarui disease",SMP00531,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glycolysis / Gluconeogenesis,,map00010
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Glycolysis / Gluconeogenesis,,map00010
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Homocarnosinosis,SMP00385,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Hyperglycinemia, non-ketotic",SMP00485,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Hyperinsulinism-Hyperammonemia Syndrome,SMP00339,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Lactic Acidemia,SMP00313,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Leigh Syndrome,SMP00196,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Mitochondrial complex II deficiency,SMP00548,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Nitrogen metabolism,,map00910
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Non Ketotic Hyperglycinemia,SMP00223,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMP00205,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMP00560,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Primary Hyperoxaluria Type I,SMP00352,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvaldehyde Degradation,SMP00459,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate Carboxylase Deficiency,SMP00350,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E2),SMP00551,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E3),SMP00550,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate kinase deficiency,SMP00559,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Pyruvate metabolism,,map00620
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Salla Disease/Infantile Sialic Acid Storage Disease,SMP00240,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Sarcosinemia,SMP00244,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Sialuria or French Type Sialuria,SMP00216,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Succinic semialdehyde dehydrogenase deficiency,SMP00567,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Tay-Sachs Disease,SMP00390,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,The oncogenic action of 2-hydroxyglutarate,SMP02291,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMP02359,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,The Oncogenic Action of Fumarate,SMP02295,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMP02358,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,The Oncogenic Action of Succinate,SMP02292,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Transfer of Acetyl Groups into Mitochondria,SMP00466,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Triosephosphate isomerase,SMP00563,
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Urea Cycle,SMP00059,map00330
Pyruvic acid,C3H4O3,CC(=O)C(O)=O,LCTONWCANYUPML-UHFFFAOYSA-N,Warburg Effect,SMP00654,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,2-Hydroxyglutric Aciduria (D And L Form),SMP00136,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,2-ketoglutarate dehydrogenase complex deficiency,SMP00549,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMP00137,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMP00138,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-hydroxyisobutyric acid dehydrogenase deficiency,SMP00521,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-hydroxyisobutyric aciduria,SMP00522,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMP00237,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type I,SMP00139,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type III,SMP00140,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,3-Methylglutaconic Aciduria Type IV,SMP00141,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMP00243,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Arginine and proline metabolism,,map00330
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMP00362,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Beta-Ketothiolase Deficiency,SMP00173,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Butyrate Metabolism,SMP00073,map00650
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Carnitine Synthesis,SMP00465,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Citric Acid Cycle,SMP00057,map00020
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Congenital lactic acidosis,SMP00546,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",SMP00504,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Fumarase deficiency,SMP00547,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Glutamate Metabolism,SMP00072,map00250
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Glutaminolysis and Cancer,SMP02298,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMP00188,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Homocarnosinosis,SMP00385,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Hyperinsulinism-Hyperammonemia Syndrome,SMP00339,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Hyperornithinemia with gyrate atrophy (HOGA),SMP00505,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMP00506,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Hyperprolinemia Type I,SMP00361,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Hyperprolinemia Type II,SMP00360,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Isobutyryl-coa dehydrogenase deficiency,SMP00523,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Isovaleric acidemia,SMP00524,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Isovaleric Aciduria,SMP00238,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Ketone Body Metabolism,SMP00071,map00072
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,L-arginine:glycine amidinotransferase deficiency,SMP00507,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Maple Syrup Urine Disease,SMP00199,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMP00384,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Methylmalonic Aciduria,SMP00200,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Mitochondrial complex II deficiency,SMP00548,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Ornithine Aminotransferase Deficiency (OAT Deficiency),SMP00363,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Oxidation of Branched Chain Fatty Acids,SMP00030,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Oxidative phosphorylation,,map00190
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Phytanic Acid Peroxisomal Oxidation,SMP00450,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Prolidase Deficiency (PD),SMP00207,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Prolinemia Type II,SMP00208,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Propionic Acidemia,SMP00236,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E2),SMP00551,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Pyruvate dehydrogenase deficiency (E3),SMP00550,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Refsum Disease,SMP00451,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Succinic semialdehyde dehydrogenase deficiency,SMP00567,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMP00569,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,The oncogenic action of 2-hydroxyglutarate,SMP02291,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMP02359,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,The Oncogenic Action of Fumarate,SMP02295,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMP02358,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,The Oncogenic Action of Succinate,SMP02292,
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,"Valine, leucine and isoleucine degradation",,map00280
Succinic acid,C4H6O4,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Warburg Effect,SMP00654,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,3-Methylthiofentanyl Action Pathway,SMP00679,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Alfentanil Action Pathway,SMP00413,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Alvimopan Action Pathway,SMP00685,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Anileridine Action Pathway,SMP00674,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Benzocaine Action Pathway,SMP00392,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Bupivacaine Action Pathway,SMP00393,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Buprenorphine Action Pathway,SMP00684,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Carfentanil Action Pathway,SMP00414,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Chloroprocaine Action Pathway,SMP00394,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Citalopram Action Pathway,SMP00424,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Cocaine Action Pathway,SMP00395,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Codeine Action Pathway,SMP00405,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Desipramine Action Pathway,SMP00423,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Dezocine Action Pathway,SMP00676,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Dibucaine Action Pathway,SMP00396,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Dihydromorphine Action Pathway,SMP00689,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Dimethylthiambutene Action Pathway,SMP00680,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Diphenoxylate Action Pathway,SMP00675,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Escitalopram Action Pathway,SMP00425,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Ethylmorphine Action Pathway,SMP00681,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMP00309,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Excitatory Neural Signalling Through 5-HTR 6 and Serotonin,SMP00312,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Excitatory Neural Signalling Through 5-HTR 7 and Serotonin,SMP00311,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Fentanyl Action Pathway,SMP00415,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Fluoxetine Action Pathway,SMP00426,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Heroin Action Pathway,SMP00407,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Hydrocodone Action Pathway,SMP00411,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Hydromorphone Action Pathway,SMP00410,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Imipramine Action Pathway,SMP00422,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Ketobemidone  Action Pathway,SMP00690,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Levallorphan Action Pathway,SMP00683,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Levobupivacaine Action Pathway,SMP00397,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Levomethadyl Acetate Action Action Pathway,SMP00677,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Levorphanol Action Pathway,SMP00673,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Lidocaine (Local Anaesthetic) Action Pathway,SMP00398,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Mepivacaine Action Pathway,SMP00399,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Methadone Action Pathway,SMP00408,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Methadyl Acetate Action Pathway,SMP00678,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Morphine Action Pathway,SMP00406,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Nalbuphine Action Pathway,SMP00691,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Naloxone Action Pathway,SMP00688,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Naltrexone Action Pathway,SMP00687,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Nicotine Action Pathway,SMP00431,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Oxybuprocaine Action Pathway,SMP00400,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Oxycodone Action Pathway,SMP00409,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Oxymorphone Action Pathway,SMP00412,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Pentazocine Action Pathway,SMP00686,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Prilocaine Action Pathway,SMP00401,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Procaine Action Pathway,SMP00402,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Proparacaine Action Pathway,SMP00403,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Propoxyphene Action Pathway,SMP00672,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Remifentanil Action Pathway,SMP00416,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Ropivacaine Action Pathway,SMP00404,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Sufentanil Action Pathway,SMP00417,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Tramadol Action Action Pathway,SMP00671,
Serotonin,C10H12N2O,NCCC1=CNC2=C1C=C(O)C=C2,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Tryptophan metabolism,,map00380
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
Tyramine,C8H11NO,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
4-Hydroxybenzoic acid,C7H6O3,OC(=O)C1=CC=C(O)C=C1,FJKROLUGYXJWQN-UHFFFAOYSA-N,Ubiquinone Biosynthesis,SMP00065,map00130
Hydroxypropionic acid,C3H6O3,OCCC(O)=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,Malonic Aciduria,SMP00198,
Hydroxypropionic acid,C3H6O3,OCCC(O)=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,Malonyl-coa decarboxylase deficiency,SMP00502,
Hydroxypropionic acid,C3H6O3,OCCC(O)=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMP00201,
Hydroxypropionic acid,C3H6O3,OCCC(O)=O,ALRHLSYJTWAHJZ-UHFFFAOYSA-N,Propanoate metabolism,,map00640
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Phenylalanine and Tyrosine Metabolism,SMP00008,map00360
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Phenylketonuria,SMP00206,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMP00369,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Tyrosinemia Type 3 (TYRO3),SMP00370,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
4-Hydroxyphenylpyruvic acid,C9H8O4,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
5-Hydroxyindoleacetic acid,C10H9NO3,OC(=O)CC1=CNC2=C1C=C(O)C=C2,DUUGKQCEGZLZNO-UHFFFAOYSA-N,Tryptophan metabolism,,map00380
Propyl alcohol,C3H8O,CCCO,BDERNNFJNOPAEC-UHFFFAOYSA-N,Sulfite oxidase deficiency,SMP00532,
Propyl alcohol,C3H8O,CCCO,BDERNNFJNOPAEC-UHFFFAOYSA-N,Sulfur metabolism,,map00920
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Acrivastine H1-Antihistamine Action,SMP59881,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Alcaftadine H1-Antihistamine Action,SMP62881,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Alimemazine H1-Antihistamine Action,SMP59689,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Antazoline H1-Antihistamine Action,SMP57584,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Astemizole H1-Antihistamine Action,SMP59897,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Azatadine H1-Antihistamine Action,SMP59865,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Azelastine H1-Antihistamine Action,SMP60741,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Bamipine H1-Antihistamine Action,SMP62882,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Bepotastine H1-Antihistamine Action,SMP60058,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Betahistine H1-Antihistamine Action,SMP60744,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Betazole Action Pathway,SMP00736,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Bilastine H1-Antihistamine Action,SMP60170,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Bromodiphenhydramine H1-Antihistamine Action,SMP58813,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Brompheniramine H1-Antihistamine Action,SMP57579,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Buclizine H1-Antihistamine Action,SMP58964,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Carbinoxamine H1-Antihistamine Action,SMP58797,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Cetirizine H1-Antihistamine Action,SMP59058,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Chlorcyclizine H1-Antihistamine Action,SMP58931,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Chloropyramine H1-Antihistamine Action,SMP57585,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Chlorphenamine H1-Antihistamine Action,SMP56661,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Chlorphenoxamine H1-Antihistamine Action,SMP58903,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Cimetidine Action Pathway,SMP00232,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Cinnarizine H1-Antihistamine Action,SMP59110,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Clemastine H1-Antihistamine Action,SMP58891,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Clocinizine H1-Antihistamine Action,SMP62788,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Cyclizine H1-Antihistamine Action,SMP58923,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Cyproheptadine H1-Antihistamine Action,SMP59694,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Deptropine H1-Antihistamine Action,SMP62883,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Desloratadine H1-Antihistamine Action,SMP60201,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Dexbrompheniramine H1-Antihistamine Action,SMP57580,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Dexchlorpheniramine H1-Antihistamine Action,SMP56811,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Dimetindene H1-Antihistamine Action,SMP57582,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Diphenhydramine H1-Antihistamine Action,SMP58785,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Diphenylpyraline H1-Antihistamine Action,SMP58908,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Doxepin H1-Antihistamine Action,SMP59872,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Doxylamine H1-Antihistamine Action,SMP58803,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Ebastine H1-Antihistamine Action,SMP60204,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Embramine H1-Antihistamine Action,SMP62622,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Emedastine H1-Antihistamine Action,SMP61040,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Epinastine H1-Antihistamine Action,SMP61191,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Esomeprazole Action Pathway,SMP00225,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Famotidine Action Pathway,SMP00231,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Fc Epsilon Receptor I Signaling in Mast Cells,SMP00358,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Fenethazine H1-Antihistamine Action,SMP59707,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Fexofenadine H1-Antihistamine Action,SMP60218,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Flunarizine H1-Antihistamine Action,SMP61047,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Gastric Acid Production,SMP00589,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Histamine H1 Receptor Activation,SMP53896,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Histamine H1 Receptor Activation,SMP63452,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Histapyrrodine H1-Antihistamine Action,SMP58732,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Histidine metabolism,SMP00044,map00340
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Histidinemia,SMP00191,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Homochlorcyclizine H1-Antihistamine Action,SMP62795,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Hydroxyethylpromethazine H1-Antihistamine Action,SMP59710,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Hydroxyzine H1-Antihistamine Action,SMP58936,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMP00335,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Isothipendyl H1-Antihistamine Action,SMP59716,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Ketotifen H1-Antihistamine Action,SMP59868,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Lafutidine H2-Antihistamine Action,SMP51038,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Lansoprazole Action Pathway,SMP00227,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Latrepirdine H1-Antihistamine Action,SMP62623,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Levocabastine H1-Antihistamine Action,SMP60224,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Levocetirizine H1-Antihistamine Action,SMP59114,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Loratadine H1-Antihistamine Action,SMP60195,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Mebhydrolin H1-Antihistamine Action,SMP61052,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Meclizine H1-Antihistamine Action,SMP58956,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Mepyramine H1-Antihistamine Action,SMP57583,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Mequitazine H1-Antihistamine Action,SMP59720,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Methapyrilene H1-Antihistamine Action,SMP58741,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Methdilazine H1-Antihistamine Action,SMP59730,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Metiamide Action Pathway,SMP00735,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Mirtazapine H1-Antihistamine Action,SMP62885,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Mizolastine H1-Antihistamine Action,SMP60230,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Nizatidine Action Pathway,SMP00233,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Olopatadine H1-Antihistamine Action,SMP60740,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Omeprazole Action Pathway,SMP00226,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Orphenadrine H1-Antihistamine Action,SMP58808,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Oxatomide H1-Antihistamine Action,SMP59044,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Oxomemazine H1-Antihistamine Action,SMP59738,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Pantoprazole Action Pathway,SMP00228,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Phenbenzamine H1-Antihistamine Action,SMP59702,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Phenindamine H1-Antihistamine Action,SMP61190,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Pheniramine H1-Antihistamine Action,SMP56662,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Phenyltoloxamine H1-Antihistamine Action,SMP58916,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Pimethixene H1-Antihistamine Action,SMP62886,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Pirenzepine Action Pathway,SMP00246,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Promethazine H1-Antihistamine Action,SMP59211,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Propiomazine H1-Antihistamine Action,SMP62625,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Pyrrobutamine H1-Antihistamine Action,SMP62887,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Quetiapine H1-Antihistamine Action,SMP62884,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Quifenadine H1-Antihistamine Action,SMP60743,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Rabeprazole Action Pathway,SMP00229,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Ranitidine Action Pathway,SMP00230,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Roxatidine acetate Action Pathway,SMP00734,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Rupatadine H1-Antihistamine Action,SMP60235,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Talastine H1-Antihistamine Action,SMP57586,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Temelastine H1-Antihistamine Action,SMP62880,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Terfenadine H1-Antihistamine Action,SMP60208,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Thenalidine H1-Antihistamine Action,SMP62894,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Thenyldiamine H1-Antihistamine Action,SMP62624,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Thiazinamium H1-Antihistamine Action,SMP60742,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Thonzylamine H1-Antihistamine Action,SMP58769,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Tolpropamine H1-Antihistamine Action,SMP62621,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Tripelennamine H1-Antihistamine Action,SMP57587,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Triprolidine H1-Antihistamine Action,SMP57581,
Histamine,C5H9N3,NCCC1=CNC=N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Tritoqualine H1-Antihistamine Action,SMP62895,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Betazole Action Pathway,SMP00736,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Cimetidine Action Pathway,SMP00232,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Esomeprazole Action Pathway,SMP00225,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Famotidine Action Pathway,SMP00231,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Gastric Acid Production,SMP00589,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Lafutidine H2-Antihistamine Action,SMP51038,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Lansoprazole Action Pathway,SMP00227,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Metiamide Action Pathway,SMP00735,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Nizatidine Action Pathway,SMP00233,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Omeprazole Action Pathway,SMP00226,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Pantoprazole Action Pathway,SMP00228,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Phospholipid Biosynthesis,SMP00025,map00564
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Pirenzepine Action Pathway,SMP00246,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Rabeprazole Action Pathway,SMP00229,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Ranitidine Action Pathway,SMP00230,
Acetylcholine,C7H16NO2,CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,Roxatidine acetate Action Pathway,SMP00734,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,27-Hydroxylase Deficiency,SMP00720,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Cerebrotendinous Xanthomatosis (CTX),SMP00315,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Congenital Bile Acid Synthesis Defect Type II,SMP00314,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Congenital Bile Acid Synthesis Defect Type III,SMP00318,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Familial Hypercholanemia (FHCA),SMP00317,
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Primary bile acid biosynthesis,,map00120
Taurodeoxycholic acid,C26H45NO6S,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,AWDRATDZQPNJFN-VAYUFCLWSA-N,Zellweger Syndrome,SMP00316,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
Pyrocatechol,C6H6O2,OC1=CC=CC=C1O,YCIMNLLNPGFGHC-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Trehalose,C12H22O11,OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,HDTRYLNUVZCQOY-LIZSDCNHSA-N,Trehalose Degradation,SMP00467,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Ethanol Degradation,SMP00449,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Glucose-6-phosphate dehydrogenase deficiency,SMP00518,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Leigh Syndrome,SMP00196,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,pentose phosphate pathway,,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Pyruvate kinase deficiency,SMP00559,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Pyruvate metabolism,,map00620
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Ribose-5-phosphate isomerase deficiency,SMP00519,
Acetaldehyde,C2H4O,CC=O,IKHGUXGNUITLKF-UHFFFAOYSA-N,Transaldolase deficiency,SMP00520,
N-Acetylmannosamine,C8H15NO6,CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-OZRXBMAMSA-N,Amino Sugar Metabolism,SMP00045,map00520
N-Acetylmannosamine,C8H15NO6,CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-OZRXBMAMSA-N,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",SMP00534,
N-Acetylmannosamine,C8H15NO6,CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-OZRXBMAMSA-N,Salla Disease/Infantile Sialic Acid Storage Disease,SMP00240,
N-Acetylmannosamine,C8H15NO6,CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-OZRXBMAMSA-N,Sialuria or French Type Sialuria,SMP00216,
N-Acetylmannosamine,C8H15NO6,CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-OZRXBMAMSA-N,Tay-Sachs Disease,SMP00390,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Leigh Syndrome,SMP00196,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Pyruvaldehyde Degradation,SMP00459,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Pyruvate kinase deficiency,SMP00559,
D-Lactic acid,C3H6O3,C[C@@H](O)C(O)=O,JVTAAEKCZFNVCJ-UWTATZPHSA-N,Pyruvate metabolism,,map00620
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Alkaptonuria,SMP00169,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Disulfiram Action Pathway,SMP00429,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Dopamine beta-hydroxylase deficiency,SMP00498,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Hawkinsinuria,SMP00190,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Monoamine oxidase-a deficiency (MAO-A),SMP00533,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,Tyrosinemia Type I,SMP00218,
"3,4-Dihydroxybenzeneacetic acid",C8H8O4,OC(=O)CC1=CC(O)=C(O)C=C1,CFFZDZCDUFSOFZ-UHFFFAOYSA-N,"Tyrosinemia, transient, of the newborn",SMP00494,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Acute Intermittent Porphyria,SMP00344,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Carnitine Synthesis,SMP00465,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Clomipramine Metabolism Pathway,SMP00639,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,SMP00345,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Degradation of Superoxides,SMP00468,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Ethanol Degradation,SMP00449,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Hereditary Coproporphyria (HCP),SMP00342,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Homocysteine Degradation,SMP00455,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Leigh Syndrome,SMP00196,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Malonic Aciduria,SMP00198,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Malonyl-coa decarboxylase deficiency,SMP00502,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMP00201,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMP00482,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMP00481,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMP00480,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Omeprazole Action Pathway,SMP00226,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Omeprazole Metabolism Pathway,SMP00613,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Oxidative phosphorylation,,map00190
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pantoprazole Action Pathway,SMP00228,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pantoprazole Metabolism Pathway,SMP00615,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Plasmalogen Synthesis,SMP00479,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Porphyria Variegata (PV),SMP00346,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Porphyrin Metabolism,SMP00024,map00860
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,"Primary hyperoxaluria II, PH2",SMP00558,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Propanoate metabolism,,map00640
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pyruvaldehyde Degradation,SMP00459,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMP00334,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pyruvate Dehydrogenase Complex Deficiency,SMP00212,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pyruvate kinase deficiency,SMP00559,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Pyruvate metabolism,,map00620
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Rabeprazole Action Pathway,SMP00229,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Rabeprazole Metabolism Pathway,SMP00616,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Threonine and 2-Oxobutanoate Degradation,SMP00452,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Transfer of Acetyl Groups into Mitochondria,SMP00466,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Trehalose Degradation,SMP00467,
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Tyrosine metabolism,,map00350
Hydrogen,H2,[H][H],UFHFLCQGNIYNRP-UHFFFAOYSA-N,Warburg Effect,SMP00654,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Cystathionine Beta-Synthase Deficiency,SMP00177,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Glycine N-methyltransferase Deficiency,SMP00222,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",SMP00570,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Hypermethioninemia,SMP00341,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Methionine Adenosyltransferase Deficiency,SMP00221,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Methionine Metabolism,SMP00033,map00270
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMP00340,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,SMP00214,
Putrescine,C4H12N2,NCCCCN,KIDHWZJUCRJVML-UHFFFAOYSA-N,Spermidine and Spermine Biosynthesis,SMP00445,
Acetone,C3H6O,CC(C)=O,CSCPPACGZOOCGX-UHFFFAOYSA-N,Ketone Body Metabolism,SMP00071,map00072
Acetone,C3H6O,CC(C)=O,CSCPPACGZOOCGX-UHFFFAOYSA-N,Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMP00569,
Hydrogen sulfide,H2S,S,RWSOTUBLDIXVET-UHFFFAOYSA-N,Beta-mercaptolactate-cysteine disulfiduria,SMP00499,
Hydrogen sulfide,H2S,S,RWSOTUBLDIXVET-UHFFFAOYSA-N,Cysteine Metabolism,SMP00013,map00270
Hydrogen sulfide,H2S,S,RWSOTUBLDIXVET-UHFFFAOYSA-N,"Cystinosis, ocular nonnephropathic",SMP00722,
Etiocholanedione,C19H28O2,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C,RAJWOBJTTGJROA-QJISAEMRSA-N,Androstenedione Metabolism,SMP30406,
"6,7-Dimethyl-8-(1-D-ribityl)lumazine",C13H18N4O6,CC1=C(C)N(C[C@H](O)[C@H](O)[C@H](O)CO)C2=NC(=O)NC(=O)C2=N1,SXDXRJZUAJBNFL-XKSSXDPKSA-N,Riboflavin Metabolism,SMP00070,map00740
Galactan,(C12H20O11)nC2H6,CO[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@H](OC)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,PTHCMJGKKRQCBF-ICIGWGHZSA-N,Galactose Metabolism,SMP00043,map00052
Phenylacetylglutamine,C13H16N2O4,NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O,JFLIEFSWGNOPJJ-JTQLQIEISA-N,Phenylalanine metabolism,,map00360
